JAMA · 2006 · 891 citations · 28 references
Public HealthEmergency MedicineInjury PreventionInjury SurveillancePharmacovigilancePublic Health SurveillanceAdverse Drug Event PreventionAdverse Drug ReactionsPharmacoepidemiologyAdverse Drug EventsAdverse Drug Reaction EpidemiologyAdverse Drug Reaction SurveillanceDrug Safety SurveillancePopulation-based Sentinel Surveillance
Adverse drug events are common and often preventable causes of medical injuries. The study aimed to describe the frequency and characteristics of outpatient adverse drug events leading to emergency department visits and to show that ongoing population‑based surveillance can guide prevention strategies. The authors conducted active surveillance from 2004 to 2005 using the National Electronic Injury Surveillance.
Adverse drug events are common and often preventable causes of medical injuries. However, timely, nationally representative information on outpatient adverse drug events is limited.To describe the frequency and characteristics of adverse drug events that lead to emergency department visits in the United States.Active surveillance from January 1, 2004, through December 31, 2005, through the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project.National estimates of the numbers, population rates, and severity (measured by hospitalization) of individuals with adverse drug events treated in emergency departments.Over the 2-year study period, 21,298 adverse drug event cases were reported, producing weighted annual estimates of 701,547 individuals (95% confidence interval [CI], 509,642-893,452) or 2.4 individuals per 1000 population (95% CI, 1.7-3.0) treated in emergency departments. Of these cases, 3487 individuals required hospitalization (annual estimate, 117,318 [16.7%]; 95% CI, 13.1%-20.3%). Adverse drug events accounted for 2.5% (95% CI, 2.0%-3.1%) of estimated emergency department visits for all unintentional injuries and 6.7% (95% CI, 4.7%-8.7%) of those leading to hospitalization and accounted for 0.6% of estimated emergency department visits for all causes. Individuals aged 65 years or older were more likely than younger individuals to sustain adverse drug events (annual estimate, 4.9 vs 2.0 per 1000; rate ratio [RR], 2.4; 95% CI, 1.8-3.0) and more likely to require hospitalization (annual estimate, 1.6 vs 0.23 per 1000; RR, 6.8; 95% CI, 4.3-9.2). Drugs for which regular outpatient monitoring is used to prevent acute toxicity accounted for 41.5% of estimated hospitalizations overall (1381 cases; 95% CI, 30.9%-52.1%) and 54.4% of estimated hospitalizations among individuals aged 65 years or older (829 cases; 95% CI, 45.0%-63.7%).Adverse drug events among outpatients that lead to emergency department visits are an important cause of morbidity in the United States, particularly among individuals aged 65 years or older. Ongoing, population-based surveillance can help monitor these events and target prevention strategies.
28
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Jerry H. Gurwitz, Terry S. Field, Leslie R. Harrold et al. · JAMA · 2003 · 1.7K citations
Pharmacy, Gynecology, Obstetrics +11
Systems analysis of adverse drug events. ADE Prevention Study Group
Making health care safer: a critical analysis of patient safety practices.
Kaveh G Shojania, Ben Duncan, Kimberly McDonald et al. · PubMed · 2001 · 1.6K citations · Full text
Pharmacy, Health Services Administration, Good Clinical Practice +5
Adverse Drug Events in Ambulatory Care
Tejal K. Gandhi, Saul N. Weingart, Joshua Borus et al. · New England Journal of Medicine · 2003 · 1.4K citations